The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Craniosacral Therapy and Acupuncture for Chronic Migraine

두개천골요법과 침치료로 호전된 만성 편두통 환자에 대한 증례보고

  • Su-jin Lee (Department of Cardiology and Neurology of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seong-Uk Park (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong ) ;
  • Jung-Mi Park (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong ) ;
  • Chang-Nam Ko (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong ) ;
  • Seung-Yeon Cho (Stroke and Neurological Disorders Center, Kyung Hee University Hospital at Gangdong )
  • 이수진 (경희대학교 대학원 한방순환신경내과학교실) ;
  • 박성욱 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 박정미 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 고창남 (강동경희대학교병원 뇌신경센터 한방내과) ;
  • 조승연 (강동경희대학교병원 뇌신경센터 한방내과)
  • Received : 2023.04.17
  • Accepted : 2023.08.22
  • Published : 2023.09.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This case report aims to describe the effects of craniosacral therapy and acupuncture in a patient with chronic migraine. Methods: A 33-year-old man with chronic migraine was treated with 20 sessions of craniosacral therapy and acupuncture for 8 weeks. The number of migraine and headache days were monitored every month. The pain intensity of headache was measured on the visual analog scale (VAS). Korean Headache Impact Test-6 (HIT-6) and Migraine Specific Quality of Life (MSQoL) were also used. Results: The number of headache days per month reduced from 28 to 7 after 8 weeks of treatment and to 3 after 3 months of treatment. The pain intensity of headache based on VAS reduced from 7.5 to 3 after 8 weeks and further to < 1 after 3 months of treatment. Furthermore, the patient's HIT-6 and MSQoL scores improved during the treatment period, which was maintained or further improved at the 3 month follow-up. No side effects were observed during or after the treatment. Conclusion: This case indicates that craniosacral therapy and acupuncture could be effective treatments for chronic migraine. Further studies are required to validate the efficacy of craniosacral therapy for chronic migraine.

Keywords

References

  1. Arnold, M. (2018).Headache classification committee of the International Headache Society (IHS): The international classification of headache disorders, 3rd edition. Cephalalgia. 38(1):1-211. Doi: 10.11770333102417738202  https://doi.org/10.11770333102417738202
  2. An H.K., Do J.K., Park J.Y., Han C.H., Lee D.K. (2007). Comparisons of life quality between chronic and episodic migraine patients. Journal of the Korean Neurological Association. 25(3):93-297. 
  3. Hovaguimian A. & Roth J. (2022). Management of chronic migraine. British medical journal. 379: e067670. Doi: 10.1136/bmj-2021-067670 
  4. Kwak M.J., Han Y.H., Geum J.H., Park S.H., Woo H.J., Ha W.B., Lee J.H. (2022). Trends in domestic and international clinical research of craniosacral therapy. Scoping Review Journal of Korean Medicine Rehabilitation. 32(3):13-27. Doi: 10.18325/jkmr.2022.32.3.13 
  5. Arnadottir T. S. & Sigurdardottir A. K. (2013). Is craniosacral therapy effective for migraine? Tested with HIT‑6 Questionnaire. 19(1):11-14. Doi: 10.1016/j.ctcp.2012.09.003 
  6. Haller H., Lauche R., Sundberg T., Dobos G., Cramer H. (2020). Craniosacral therapy for chronic pain: a systematic review and meta-analysis of randomized controlled trials. BMC Musculoskeletal Disorders. 21(1):1. Doi: 10.1186/s12891-019-3017-y. ISSN 1471-2474. 
  7. Upledger J. E. & Vrendevoogd J. D. (1983). Craniosacral therapy. 3rd ed. Seattle:Eastland Press. 
  8. Blumenfeld A. M., Kaur G., Mahajan A., Shukla H., Sommer K., Tung A., Knievel K. L. (2022). Effectiveness and safety of chronic migraine preventive treatments: A Systematic Literature Review. Pain and Therapy. 12(1):251-274. Doi: 10.1007/s40122-022-00452-3 
  9. Jensen M. P., Chen C., Brugger A. M. (2003). Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. Journal of Pain. 4(7):407-414. Doi: 10.1016/s1526-5900(03)00716-8 
  10. Kosinski M., Bayliss M.S., Bjorner J.B., Ware J.E., Garber W.H., Batenhorst A., Cady R., Dahlof C.G.H., Dowson A., Tepper S. (2003). A six-item short-form survey for measuring headache impact: the HIT-6. Quality of life research. 12(8):963-974. Doi: 10.1023/A:1026119331193 
  11. Chu M.K., Im H.J., Ju Y.S., Yu K.H., Ma H.I., Kim Y.J., Kim J.Y., Lee B.C. (2009). Validity and reliability assessment of Korean headache impact test-6 (HIT-6). Journal of the Korean Neurological Association. 27(1):1-6. 
  12. Lipton R.B., Stewart W.F., Sawyer J., Edmeads J.G.(2001). Clinical utility of an instrument assessing migraine disability:the Migraine Disability Assessment(MIDAS) questionnaire. Headache.;41(9):854-861.  https://doi.org/10.1111/j.1526-4610.2001.01156.x
  13. Khara M. S., Marianne S. R., Werner J. B., Suzanne N. C., Rose G., Gordon F. M., Arnoldas G. E., Marek J. G. (2010). HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 50(3):383-395. Doi: 10.1111/j.1526-4610.2009.01544.x 
  14. Wagner T.H., Patrick D.L., Galer B.S., Berzon R.A. (1996). A new instrument to assess the long-term quality of life effects from migraine: development and psychometric testing of the MSQOL. Headache. 36(8):484-492. Doi: 10.1046/j.1526-4610.1996.3608484.x 
  15. Moon H.S., Chung C.S., Lee H.S., Park H.S., Kim S.W., Woo H.W. (2003). The reliability and validity of the migraine-specific quality of life questionnaire for Korean migraine suffers. Journal of the Korean Neurological Association. 21(2):146-155. 
  16. Moon H.S. (2018). Comprehensive review and update on chronic migraine. Journal of Korean American Medical Association. 61(5):314-322. Doi: 10.5124/jkma.2018.61.5.314 
  17. Ishii R., Schwedt T.J., Dumkrieger G., Lalvani N., Craven A., Goadsby P. J., Lipton R. B., Olesen J., Silberstein S. D., Burish M. J., Dodick D. W. (2021). Chronic versus episodic migraine: The 15-day threshold does not adequately reflect substantial differences in disability across the full spectrum of headache frequency. Headache. 61(7):992-1003. Doi: 10.1111/head.14154 
  18. Sauro K.M., Rose M.S., Becker W.J., Christie S.N., Giammarco R., Mackie G.F., Eloff A.G., Gawel M.J. (2010). HIT-6 and MIDAS as measures of headache disability in a headache referral population. Headache. 50(3):383-395. Doi: 10.1111/j.1526-4610.2009.01544.x 
  19. Zhang N., Houle T., Hindiyeh N., Aurora S. K. (2020). Systematic review: acupuncture vs standard pharmacological therapy for migraine prevention. Headache. 60(2):309-317. Doi: 10.1111/head.13723 
  20. Lee S.J., Lee S.H., Heo I., Hwang E.H., Lim H.H., Song Y.K. (2020). Chuna craniosacral therapy for headache: a systematic review and meta analysis. The Journal of Korea CHUNA Manual Medicine for Spine & Nerves. 15(1):35-48. Doi: 10.30581/jkcmm.2020.15.1.35